Vitamin D3 as adjunctive therapy in the treatment of depression in tuberculosis patients: a short-term pilot randomized double-blind controlled study
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Objective: We aimed to evaluate whether high-dose cholecalciferol has beneficial effects on depression in pulmonary tuberculosis (PTB) patients. Methods: This pilot, randomized, and double-blind trial enrolled 123 recurrent PTB patients (aged ≥18 years) meeting Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) criteria of major depressive disorder from four hospitals in Southeast China. Patients were randomly assigned to 8-week oral treatment with 100,000 IU/week cholecalciferol (Vit D group) or a matching placebo (control group). The primary outcome was treatment response, defined as a 50% reduction in symptoms and change in scores of the Chinese version of Beck Depression Inventory (BDI) from baseline to 8 weeks. Relative risks of depression were estimated using multivariable logistic regression. Results: Finally, 120 patients were enrolled, including 56 test patients and 64 controls. After 8 weeks, the treatment response or BDI scores did not differ significantly between groups. Multivariate logistic regression showed that BDI scores were not significantly improved in the Vit D group after adjustment for age, time to first negative smear, or 25-hydroxyvitamin D level. Conclusion: The use of high-dose Vit D3 supplementation may not be warranted for reducing depressive symptoms in the PTB population. Nevertheless, this finding should be validated by further large-scale studies according to different kinds of depression or Vit D receptor polymorphism genotype. Keywords: vitamin D, major depressive disorders, depression, tuberculosis, Mycobacterium tuberculosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Only one study31 had a low risk of bias score on all the items on Cochrane tool for the assessment of intervention studies, the rest were classified as having high risk of bias.”
From Pharmacological or non-pharmacological interventions for treatment of common mental disorders associated with Tuberculosis: A systematic review (2021) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Two articles evaluated pharmacological interventions (antidepressants and Vitamin D).”
From Pharmacological or non-pharmacological interventions for treatment of common mental disorders associated with Tuberculosis: A systematic review (2021) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Depression Is the Leading Cause of Disability Around the World
Friedrich, M. J. (2017) · JAMA · doi:10.1001/jama.2017.3826 · Cited by 1,459 · cited 1×
“4% since 2005.(5) Both depressive disorders and subthreshold depressive symptoms substantially threaten health and economy.”
BackgroundDepression, Disability Days, and Days Lost From Work in a Prospective Epidemiologic Survey
Broadhead, W. E. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450190056028 · Cited by 1,237 · cited 1×
“Both depressive disorders and subthreshold depressive symptoms substantially threaten health and economy.(6,7) Depression in PTB individuals is associated with delayed sought of health care and poor treatment compliance, which can lead to drug resistance, morbidity, and mortality.”
BackgroundKaton, W., Lin, E. H. B., & Kroenke, K. (2007) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2006.11.005 · Cited by 965 · cited 1×
“Finally, no evidence suggests that TB and depression may share risk factors.(38,39) Immunological responses have been implicated in the association between chronic disease and depression.”
BackgroundEpidemiology and treatment of depression in patients with chronic medical illness
J. Katon, W. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/wkaton · Cited by 820
Vitamin D deficiency and depression in adults: systematic review and meta-analysis
Anglin, R. E. S., Samaan, Z., Walter, S. D., & McDonald, S. D. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.106666 · Cited by 820
Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis
Nnoaham, K. E., & Clarke, A. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dym247 · Cited by 681 · cited 1×
“Tuberculosis (TB) patients are at an increased risk of 25-hydroxyvitamin D (25(OH)D) deficiency compared with the general population.(9,10) Several randomized trials report the effectiveness or safety of vitamin D (Vit D) supplementation to standard TB treatment, but bring about conflicting findings.”
BackgroundEfficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level
Vieth, R., Chan, P.-C. R., & MacFarlane, G. D. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.288 · Cited by 616 · cited 1×
“However, the existing studies are limited by the use of unrepresentative samples (Alzheimer’s disease, Parkinson’s disease or psychiatric disorders), different diagnostic tools for quantification of depressive symptoms, co-interventions (eg, calcium or psychotropic drugs), and insufficient doses (,2,000 IU daily) to a…”
BackgroundMartineau, A. R., Timms, P. M., Bothamley, G. H., Hanifa, Y., Islam, K., Claxton, A. P., Packe, G. E., Moore-Gillon, J. C., Darmalingam, M., Davidson, R. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61889-2 · Cited by 580
Depression and immune function
Kiecolt-Glaser, J. K., & Glaser, R. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00309-4 · Cited by 571 · cited 2×
“Finally, no evidence suggests that TB and depression may share risk factors.(38,39) Immunological responses have been implicated in the association between chronic disease and depression.”
BackgroundFloyd, K., Glaziou, P., Zumla, A., & Raviglione, M. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30057-2 · Cited by 440 · cited 1×
“Background Pulmonary tuberculosis (PTB), a chronic infectious disease, was the second major cause of death worldwide in 2016.(1) PTB patients are faced with higher rates of comorbid depression compared with the general population.”
Background
Cited by
Jamilian, H., Amirani, E., Milajerdi, A., Kolahdooz, F., Mirzaei, H., Zaroudi, M., Ghaderi, A., & Asemi, Z. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109651 · Cited by 154
Mikola, T., Marx, W., Lane, M. M., Hockey, M., Loughman, A., Rajapolvi, S., Rocks, T., O'Neil, A. E., Mischoulon, D., Valkonen‐Korhonen, M., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2096560 · Cited by 101
“In single studies, adverse events such as bone and joint pain, nausea, diarrhea, and itching led to discontinuation of five (Wang et al. 2016) and two (Zhang et al. 2018) participants from the vitamin D group.”
BackgroundInfluentialXie, F., Huang, T., Lou, D., Fu, R., Ni, C., Hong, J., & Ruan, L. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.903547 · Cited by 76
Meng, J., Li, X., Xiong, Y., Wu, Y., Liu, P., & Gao, S. (2024) · Infection · doi:10.1007/s15010-024-02446-z · Cited by 43
“8 studies [7, 9, 22, 24, 28, 33, 35] administered vitamin D weekly, with weekly dosages ranging from 50,000 IU to 140,000 IU.”
Farooq, S., Tunmore, J., & Comber, R. (2021) · Chronic Respiratory Disease · doi:10.1177/14799731211003937 · Cited by 31
“Two studies evaluated pharmacological interventions.(31,32) Table 1 describes the characteristics of the final included studies in this review, including; author, year, country, setting, population, method, design and sample characteristics.”
BackgroundMethod
Metadata
- Authors
- Zhang, L., Wang, S., Zhu, Y., & Yang, T.
- Affiliations
- Ningbo No. 2 Hospital (CN)
- Ningbo Center for Disease Control and Prevention (CN)
- Corresponding author
- Yang, Tianchi
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2018-11
- Volume
- Volume 14
- Pages
- 3103-3109
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- PMC
- PMC6241718
- OpenAlex
- W2900822211
- Cited by
- 16
- References
- 44
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 2 · 2019: 2
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Keywords
- vitamin D3, depression, pulmonary tuberculosis, major depressive disorder, adjunctive therapy, high-dose vitamin D supplementation, Beck Depression Inventory, 25-hydroxyvitamin D, tuberculosis relapse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vitamin D3 as adjunctive therapy in the treatment of depression in tuberculosis patients: a short-term pilot randomized double-blind controlled study. https://app.cochat.ai/papers/10.2147/ndt.s183039
- The paper
- Zhang, L., Wang, S., Zhu, Y., & Yang, T. (2018). Vitamin D3 as adjunctive therapy in the treatment of depression in tuberculosis patients: a short-term pilot randomized double-blind controlled study. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s183039
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
